Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Oct 11, 2024
Dividend Increases/Decreases for the Week of October 11
Let's take a look at firms raising/lowering their dividends this week. Dec 11, 2023
Oracle’s “Business Is Good and Getting Better”
Image Source: Peter Kaminski. On December 11, Oracle reported mixed second-quarter results for its fiscal 2024 that showed total revenue advancing 5% on a year-over-year basis (4% in constant currency), slightly lower than expectations, and non-GAAP earnings per share of $1.34 that came in slightly ahead of what the market was looking for. The company’s non-GAAP operating margin of 43% in the quarter helped to drive non-GAAP net income 14% higher than the same period a year ago (11% in constant currency). We’re not letting the slight miss on the top line sway us from our constructive stance on shares. Our fair value estimate stands at $108 per share, about in-line with where shares are currently trading. Dec 10, 2023
First Gene-Editing Therapy Coming to Market; Reiterating Our Positive Stance on Vertex Pharma
Credit: Darryl Leja, NHGRI. On December 8, 2023, the U.S. Food and Drug Administration announced that it had approved Vertex Pharma’s and CRISPR Therapeutics’ novel gene-editing therapy (“Casgevy” – exa-cel) for sickle cell disease [SCD] in patients that are 12 years of age or older. This is the first such approval of its kind in U.S. history and will likely open the door for more gene-editing therapies for other rare diseases in the future. Estimates indicate that roughly 16,000 people will be eligible for the treatment at an estimated cost of around $2.2 million each, according to Reuters. The one-time market size of roughly $35.2 billion is a needle-mover, but the pace and timing of adoption of the therapy among the eligible population is difficult to estimate at this time. Note also that the therapy is of one-time application, meaning the therapy is a functional cure and will not be a source of recurring revenue from each patient. Nevertheless, it is an exciting development for medical science. Nov 3, 2023
People Love Their Starbucks
Image: Starbucks remains a strong free cash flow generator. Operational efficiencies, sales leverage and pricing strength helped drive Starbucks' GAAP operating income growth of 42.7% and non-GAAP earnings per share to $1.06 in the quarter, up 31% on a year-over-year basis. Starbucks ended its fourth quarter of fiscal 2023 with ~$3.95 billion in cash and short-term investments and short- and long-term debt of ~$15.4 billion, resulting in a net debt position on the books. Free cash flow generation remains robust at Starbucks, however, with the measure coming in at ~$3.7 billion for the fiscal year ending October 1, 2023. We’re reiterating the high end of our fair value estimate range of $120 for Starbucks’ shares. Oct 13, 2023
Dividend Increases/Decreases for the Week of October 13
Let's take a look at firms raising/lowering their dividends this week. Mar 28, 2023
The Real Reason Why Moats Matter
Image Source: Ray in Manila. Let's sit down with President of Investment Research Brian Nelson for his take on economic moats, and why he still likes the areas of large cap growth and big cap tech. Oct 27, 2022
VBI Ratings Not as Impressive As We Would Have Liked in 2022
Image: How the VBI rating system has ranked equities so far this year. At Valuentum, we use the Valuentum Buying Index (VBI) to source ideas into diversified simulated newsletter portfolios, and the VBI may be most applicable to the simulated Best Ideas Newsletter portfolio, where we generally like to include ideas when they register a high VBI rating and remove them when they register a low VBI rating. We always use the VBI in a portfolio setting and never by itself. Let's talk more about the VBI rating system in this work. Oct 14, 2022
Dividend Increases/Decreases for the Week of October 14
Let's take a look at firms raising/lowering their dividends this week. Jul 27, 2022
Lockheed Martin Facing Near Term Headwinds; Longer Term Outlook Remains Bright
Image Source: Lockheed Martin Corporation – Second Quarter of Fiscal 2022 IR Earnings Presentation. Lockheed Martin Corp reported earnings for the second quarter of fiscal 2022 (period ended June 26, 2022) that missed consensus top- and bottom-line estimates, largely due to delays in securing another domestic F-35 contract and supply chain hurdles. In our view, these are near term headwinds that are resolvable. Reportedly, Lockheed Martin is nearing a deal worth ~$30 billion with the US Department of Defense (‘DoD’) covering orders for around 375 F-35 aircraft. As it concerns supply chain hurdles, the resumption of normal economic activities (as the worst of the COVID-19 pandemic is put behind the world economy) should steadily allow industrial supplies and global logistics networks to catch up. These headwinds forced Lockheed Martin to reduce its guidance for fiscal 2022 in conjunction with its latest earnings update, specifically as it concerns its revenue and diluted EPS forecasts, though the defense contractor maintained its free cash flow and ‘segment operating profit’ guidance. We continue to like Lockheed Martin in the Dividend Growth Newsletter portfolio. The geopolitical backdrop (with an eye towards the Ukraine-Russia crisis, rising tensions between the US and China, and Western concerns with Iran and North Korea’s nuclear programs) is conducive for increased national defense spending in the U.S. and Western aligned nations across the globe. Lockheed Martin is well-positioned to meet those needs. Shares of LMT yield ~2.8% as of this writing. Jul 8, 2022
Industrial Bellwethers A Mixed Bag: GE, BA, CAT, DE, UNP
Image Source: Caterpillar Inc – May 2022 Caterpillar Investor Day Presentation. In this article, we cover the industrial landscape by digging into the recent financial and operational performance of General Electric Company, Boeing Co, Caterpillar Inc, Deere & Company, and Union Pacific Corporation. Common themes include robust demand for their offerings, healthy order backlogs, and meaningful pricing power, though headwinds include substantial inflationary pressures, supply chain hurdles, and in certain instances, geopolitical tensions. General Electric will soon separate into three different publicly traded companies, and on a consolidated basis the firm is doing much better than years past. In 2022 and on a non-GAAP basis, General Electric is guiding for a 150+ basis point expansion in its adjusted organic operating margin and high-single-digit organic revenue growth, along with $2.80-$3.50 in adjusted EPS and $5.5-$6.5 billion in free cash flow (as defined by the company). Boeing’s financials continue to be in bad shape, and its operations continue to be plagued by missteps. The aerospace giant exited March 2022 with a massive net debt load of ~$45.5 billion (inclusive of short-term debt) after generating negative free cash flows in each year from 2019-2021. The company also generated negative free cash flows during the first quarter of 2022. Large working capital builds due to its inability to deliver certain aircraft, a product of its lackluster operational execution and regulatory intervention, is largely why Boeing has had difficulties generating positive free cash flows in recent years. Caterpillar’s first-quarter 2022 results were plagued by margin issues. In the period, the earth moving equipment maker’s GAAP revenues grew 14% year-over-year, but its manufacturing segment only posted a 3% year-over-year increase in operating income as higher costs weighed negatively on its profitability, offsetting pricing increases and increasing economies of scale. Caterpillar’s GAAP operating margin fell by ~140 basis points year-over-year in the first quarter, declining to 13.9%. During the first half of fiscal 2022, Deere’s GAAP revenues grew by 8% though its GAAP operating profit declined by 4% year-over-year, but the company’s performance in the fiscal second quarter indicates recent pricing actions have started to have a positive impact on its bottom-line performance. Deere raised its full-year earnings guidance in conjunction with its fiscal second quarter earnings update and now expects it will post $7.0-$7.4 billion in earnings this fiscal year. Union Pacific noted that its business volumes are measured by total revenue carloads increased by 4% year-over-year in the first quarter with strong growth seen at its agricultural and industrial freight volumes. The railroad company’s ‘operating income’ rose 19% year-over-year as its business continued to benefit from ongoing optimization efforts in the first quarter of 2022. The railroad operator remains very shareholder friendly and intends to payout roughly 45% of its earnings to investors as dividends. The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|